-
1
-
-
84866784798
-
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy
-
22039576
-
D.G.DeNardo, D.J.Brennan, E.Rexhepaj, B.Ruffell, S.L.Shiao, S.F.Madden, W.M.Gallagher, N.Wadhwani, S.D.Keil, S.A.Junaid et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011; 1(1):54-67; PMID:22039576; http://dx.doi.org/10.1158/2159-8274.CD-10-0028
-
(2011)
Cancer Discov
, vol.1
, Issue.1
, pp. 54-67
-
-
DeNardo, D.G.1
Brennan, D.J.2
Rexhepaj, E.3
Ruffell, B.4
Shiao, S.L.5
Madden, S.F.6
Gallagher, W.M.7
Wadhwani, N.8
Keil, S.D.9
Junaid, S.A.10
-
2
-
-
84903730485
-
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
-
24842267
-
S.Muenst, A.R.Schaerli, F.Gao, S.Däster, E.Trella, R.A.Droeser, M.G.Muraro, P.Zajac, R.Zanetti, W.E.Gillanders et al. Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat 2014; 146(1):15-24; PMID:24842267; http://dx.doi.org/10.1007/s10549-014-2988-5
-
(2014)
Breast Cancer Res Treat
, vol.146
, Issue.1
, pp. 15-24
-
-
Muenst, S.1
Schaerli, A.R.2
Gao, F.3
Däster, S.4
Trella, E.5
Droeser, R.A.6
Muraro, M.G.7
Zajac, P.8
Zanetti, R.9
Gillanders, W.E.10
-
3
-
-
84879795618
-
The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
-
23756627
-
S.Muenst, S.D.Soysal, F.Gao, E.C.Obermann, D.Oertli, W.E.Gillanders. The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer. Breast Cancer Res Treat 2013; 139(3):667-76; PMID:23756627; http://dx.doi.org/10.1007/s10549-013-2581-3
-
(2013)
Breast Cancer Res Treat
, vol.139
, Issue.3
, pp. 667-676
-
-
Muenst, S.1
Soysal, S.D.2
Gao, F.3
Obermann, E.C.4
Oertli, D.5
Gillanders, W.E.6
-
4
-
-
84861178107
-
Clinical evaluation of TRICOM vector therapeutic cancer vaccines
-
22595052
-
R.A.Madan, M.Bilusic, C.Heery, J.Schlom, J.L.Gulley. Clinical evaluation of TRICOM vector therapeutic cancer vaccines. Semin Oncol 2012; 39(3):296-304; PMID:22595052; http://dx.doi.org/10.1053/j.seminoncol.2012.02.010
-
(2012)
Semin Oncol
, vol.39
, Issue.3
, pp. 296-304
-
-
Madan, R.A.1
Bilusic, M.2
Heery, C.3
Schlom, J.4
Gulley, J.L.5
-
5
-
-
79959552163
-
Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials
-
21692698
-
E.A.Mittendorf, G.Alatrash, H.Xiao, G.T.Clifton, J.L.Murray, G.E.Peoples. Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials. Expert Rev Vaccines 2011; 10(6):755-74; PMID:21692698; http://dx.doi.org/10.1586/erv.11.59
-
(2011)
Expert Rev Vaccines
, vol.10
, Issue.6
, pp. 755-774
-
-
Mittendorf, E.A.1
Alatrash, G.2
Xiao, H.3
Clifton, G.T.4
Murray, J.L.5
Peoples, G.E.6
-
6
-
-
0034503089
-
Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer
-
11193781
-
T.P.Fleming, M.A.Watson. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 2000; 923:78-89; PMID:11193781; http://dx.doi.org/10.1111/j.1749-6632.2000.tb05521.x
-
(2000)
Ann N Y Acad Sci
, vol.923
, pp. 78-89
-
-
Fleming, T.P.1
Watson, M.A.2
-
7
-
-
0037058679
-
Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer
-
12432553
-
A.Jaramillo, K.Majumder, P.P.Manna, T.P.Fleming, G.Doherty, J.F.Dipersio, T.Mohanakumar. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer 2002; 102(5):499-506; PMID:12432553; http://dx.doi.org/10.1002/ijc.10736
-
(2002)
Int J Cancer
, vol.102
, Issue.5
, pp. 499-506
-
-
Jaramillo, A.1
Majumder, K.2
Manna, P.P.3
Fleming, T.P.4
Doherty, G.5
Dipersio, J.F.6
Mohanakumar, T.7
-
8
-
-
84874664652
-
Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells
-
22678162
-
V.Tiriveedhi, T.P.Fleming, P.S.Goedegebuure, M.Naughton, C.Ma, C.Lockhart, F.Gao, W.E.Gillanders, T.Mohanakumar. Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells. Breast Cancer Res Treat 2013; 138(1):109-18; PMID:22678162; http://dx.doi.org/10.1007/s10549-012-2110-9
-
(2013)
Breast Cancer Res Treat
, vol.138
, Issue.1
, pp. 109-118
-
-
Tiriveedhi, V.1
Fleming, T.P.2
Goedegebuure, P.S.3
Naughton, M.4
Ma, C.5
Lockhart, C.6
Gao, F.7
Gillanders, W.E.8
Mohanakumar, T.9
-
9
-
-
46949097101
-
Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers
-
17874294
-
A.Bharat, N.Benshoff, T.P.Fleming, J.R.Dietz, W.E.Gillanders, T.Mohanakumar. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers. Breast Cancer Res Treat 2008; 110(3):453-63; PMID:17874294; http://dx.doi.org/10.1007/s10549-007-9741-2
-
(2008)
Breast Cancer Res Treat
, vol.110
, Issue.3
, pp. 453-463
-
-
Bharat, A.1
Benshoff, N.2
Fleming, T.P.3
Dietz, J.R.4
Gillanders, W.E.5
Mohanakumar, T.6
-
10
-
-
84918783221
-
Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer
-
25451106
-
V.Tiriveedhi, N.Tucker, J.Herndon, L.Li, M.Sturmoski, M.Ellis, C.Ma, M.Naughton, A.C.Lockhart, F.Gao et al. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer. Clin Cancer Res 2014; 20(23):5964-75; PMID:25451106; http://dx.doi.org/10.1158/1078-0432.CCR-14-0059
-
(2014)
Clin Cancer Res
, vol.20
, Issue.23
, pp. 5964-5975
-
-
Tiriveedhi, V.1
Tucker, N.2
Herndon, J.3
Li, L.4
Sturmoski, M.5
Ellis, M.6
Ma, C.7
Naughton, M.8
Lockhart, A.C.9
Gao, F.10
|